Stock Earnings

Question 1

What are Ionis Pharmaceuticals Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Ionis Pharmaceuticals Inc has a total asset of $3,003, Net loss of $-453

Question 2

What are the key financial ratios for IONS?

Accepted Answer

Ionis Pharmaceuticals Inc's Current ratio is 1.24, has a Net margin is -64.25, sales per share of $4.71.

Question 3

How is Ionis Pharmaceuticals Inc's revenue broken down by segment or geography?

Accepted Answer

Currently Ionis Pharmaceuticals Inc data is not available.

Question 4

Is Ionis Pharmaceuticals Inc profitable?

Accepted Answer

no, according to the latest financial statements, Ionis Pharmaceuticals Inc has a net loss of $-453

Question 5

Does Ionis Pharmaceuticals Inc have any liabilities?

Accepted Answer

yes, Ionis Pharmaceuticals Inc has liability of 2,415

Question 6

How many outstanding shares for Ionis Pharmaceuticals Inc?

Accepted Answer

Ionis Pharmaceuticals Inc has a total outstanding shares of 157.9

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	966	705	787	587	810	729
Revenue Growth (YoY)	20%	-10%	34%	-28%	11%	-35%
Cost of Revenue	11	11	9	14	10	11
Gross Profit	955	693	778	573	799	717
Selling, General & Admin	351	267	212	150	170	332
Research & Development	881	901	899	833	635	526
Operating Expenses	1,233	1,169	1,112	983	806	859
Other Non Operating Income (Expenses)	-72	-72	-67	-7	-1	0
Pretax Income	-258	-460	-333	-258	-29	-134
Income Tax Expense	-2	-6	32	11	0	345
Net Income	-256	-453	-366	-269	-28	-444
Net Income Growth	-28%	24%	36%	861%	-94%	-260%
Shares Outstanding (Diluted)	159.76	149.51	143.19	141.8	141	139.6
Shares Change (YoY)	8%	4%	1%	1%	1%	-9%
EPS (Diluted)	-1.6	-3.03	-2.55	-1.9	-0.2	-3.18
EPS Growth	-34%	19%	35%	850%	-94%	-275%
Free Cash Flow	-302	-546	-331	-290	18	0
Free Cash Flow Per Share	-1.89	-3.65	-2.31	-2.04	0.12	0
Gross Margin	98.86%	98.29%	98.85%	97.61%	98.64%	98.35%
Operating Margin	-28.77%	-67.37%	-42.31%	-69.84%	-0.74%	-19.34%
Profit Margin	-26.5%	-64.25%	-46.5%	-45.82%	-3.45%	-60.9%
Free Cash Flow Margin	-31.26%	-77.44%	-42.05%	-49.4%	2.22%	0%
EBITDA	-275	-464	-321	-394	11	-126
EBITDA Margin	-28.46%	-65.81%	-40.78%	-67.12%	1.35%	-17.28%
D&A For EBITDA	3	11	12	16	17	15
EBIT	-278	-475	-333	-410	-6	-141
EBIT Margin	-28.77%	-67.37%	-42.31%	-69.84%	-0.74%	-19.34%
Effective Tax Rate	0.77%	1.3%	-9.6%	-4.26%	0%	-257.46%

Ionis Pharmaceuticals Inc (IONS) Price